Note: Articles may be assigned to more than one subject area, as a result the sum of the subject research outputs may not equal the overall research outputs. Note: Hover over the donut graph to view ...
Xenetic to supply recombinant DNase I to Tokyo Medical University for evaluation as a treatment of Ewing sarcoma in unique preclinical model FRAMINGHAM, MA / ACCESSWIRE / October 17, 2024 / Xenetic ...
Tokyo Medical and Dental University (TMDU) and Celaid Therapeutics Inc. (Celaid) are pleased to announce the signing of a joint research agreement. This agreement was established for research and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback